Abstract Submission Deadline:
November 1st, 2022
Speakers
-
Prof. Wolfgang Baumeister
PhD, GermanyProfessor, Max Pank Institute, Martinsried, Germany
Director, Max Pank Institute of Biochemistry
Head of Department of Structural Biology
Structure and function of molecular machines, in particular supramolecular assemblies involved in protein quality control such as the 26S proteasome as the giant tripeptidylpeptidase complex.
-
Matthew Bogyo
PhD, USAProfessor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology, Stanford University, Stanford, CA
Bogyo group is made up of a mix of synthetic organic chemists, biochemists, and cell biologists. They use synthetic chemistry to build new reagents that allow protease activity to be monitored in complex biological samples including cells, tissues and whole animals. They are applying these tools to 1) functional studies of cysteine and serine proteases in the life cycle stages of the human parasites Toxoplasma gondii and Plasmodium falciparum 2) in vivo imaging of multiple classes of proteases during the process of tumorigenesis.
-
Marie-Pierre Bousquet-Dubouch
PhD, FranceAssociate Professor, Department of Structural Biology and Biophysics, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France
Structural and functional analysis of human proteasome complexes.
-
Niki Chondrogianni
PhD, GreeceProfessor, National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry & Biotechnology, Athens, Greece
Chondrogianni laboratory scientific activities focus in the identification of factors and pathways that regulate human aging with particular interest on the regulation of the proteasome and protein degradation during aging and senescence. Has recently started working with the C. elegans model organism.
-
Olivier Coux
PhD, FranceProfessor, Montpellier Cell Biology Research Center, Universite´ de Montpellier, Montpellier, France
Coux laboratory studies the complex mechanisms that control the specific and regulated degradation of intracellular proteins. They study primarily the regulation, biological functions and mechanisms of action of PA28, one of these proteasome regulators. PA28γ is involved in the control of the cell nucleus architecture and in the stress response, and seems to play a key role in the development of certain cancers.
-
Kelvin Davies
PhD, DSc, FRSC, FRCPProfessor of Molecular Biology & Biochemistry, USC Leonard Davis School of Gerontolgy, Los Angeles, CA, USA
Executive Vice Dean, Dean of Faculty and Dean of Research
James E. Birren Chair in Gerontology
Director, Ethel Percy Andrus Gerontology Center
Director, USC-Buck Biology of Aging PhD ProgramDegradation of oxidatively damaged proteins by the proteasome and the mitochondrial Lon protease.
-
Cordula Enenkel
PhD, CanadaAssociate Professor, Biochemistry and Chemistry, University of Toronto, Toronto, Canada
Enenkel laboratory research focuses on the intracellular dynamics of proteasomes. Their work uses cell imaging techniques monitoring GFP-labelled proteasomes in proliferating yeast and mammalian cancer which has lead to the observation that that proteasomes are primarily nuclear during cell division.
-
Bertrand Friguet
PhD, FranceProfesseur, Integrative Cellular Ageing And Inflammation, Institute De Biologie, Paris, France
Our goals are to elucidate the role of protein oxidation as well as oxidized protein degradation and repair during cellular ageing ex vivo and in vitro and in situations of oxidative stress leading to accelerated ageing with relevant human cellular models.
-
Michal Glickman
PhD, IsraelProfessor, Department of Biology, Technion, Israel Institute of Technology, Haifa, Israel
The Israel Isaac and Natalia Kudish Academic Chair
Our group mainly focuses on Ubiquitin proteasome System (UPS) research and its contribution towards neurodisorders.
-
Alfred Goldberg
PhD, USAProfessor of Cell Biology, Harvard Medical School, Boston, MA, USA
The Goldberg laboratory is attempting to understand why the cell's machinery destroys only damaged proteins, leaving normal proteins untouched. They are also studying how protein breakdown is important in the body's immune defenses, why the destruction process goes into high gear in certain disease states such as cancer, and how this excessive destruction can be controlled.
-
Michael Groll
PhD, GermanyProfessor, Department of Chemistry, Technische Universität München, München, Germany
Chair of Biochemistry
Groll laboratory investigates the structure and function of proteasomes.
-
Mark Hochstrasser
PhD, USAEugene Higgins Professor of Molecular Biophysics and Biochemistry and Professor of Molecular, Cellular, and Developmental Biology, Yale School of Medicine, New Haven, CT, USA
Hochstrasser laboratory is interested in understanding the assembly process of the proteasome because this has important implications for how cells regulate their proteolytic capacity to suit their needs. Moreover, a regulated process such as proteasome assembly can provide an interesting target for pharmacological intervention.
-
Lan Huang
PhD, USAProfessor, Physiology & Biophysics, University of California, Irvine, CA, USA
Research Interest
biological mass spectrometry/proteomics, ubiquitin-proteasome degradation pathways, protein complexes, posttranslational modifications, protein-protein interaction
-
Julien Marcoux
PhD, FranceResearch Associate, Department of Structural Biology and Biophysics, Institute of Pharmacology and Structural Biology, Toulouse, France
Dr. Marcoux research interests are focused on using mass spectrometry as a tool for studying soluble and membrane associated protein assemblies.
-
Seth Margolis
PhD, USAAssociate Professor, Department of Biological Chemistry and Sol Snyder Department of Neuroscience, Johns Hopkins Medicine, Baltimore, MD, USA
Formation and function of the neuronal membrane proteasome; proteostasis; neuronal survival and neurodegeneration.
-
Silke Meiners
PhD, GermanyProfessor, Head Research Group Immunology and Cell Biology at the Research Center Borstel / Leibniz Lung Center, Borstel, Germany
Chair Immunoproteasome Research at the Christian-Albrechts University in Kiel, Germany
Meiners’ laboratory investigates the role of proteasomal protein degradation in chronic lung diseases.
-
Yifat Merbl
PhD, IsraelPrincipal Investigator, Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
The Merbl group employs advanced high-throughput immuno-proteomic, proteomics and genomic methods, cell biology, biochemistry and in-vivo models to reveal new proteostasis control mechanisms. The group combine their expertise to gain novel insight on basic research questions as well as develop cutting-edge technologies to transform our ability to analyze the proteomic landscape.
-
Anthony O’Donoghue
PhD, USAAssistant Professor In Residence, School of Pharmacy and Pharmaceutical Science, UC San Diego, San Diego, CA, USA
O’Donoghue laboratory interests lie in the detection and characterization of proteolytic enzymes that are involved in disease. In particular, they are interested in understanding the role of peptidases/proteases at host-pathogen and tumor-stroma interfaces.
-
Kapil Ramachandran
PhD, USAJr. Fellow of the Society of Fellows, Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA
Our laboratory seeks a complete understanding of a fundamental and novel mechanism of neuronal protein homeostasis which is co-opted into a new form of neuromodulation.
-
Tommer Ravid
Professor, The Hebrew University of Jerusalem, Israel -
Erin Schuman
PhD, GermanyProfessor, Max Pank Institute, Frankfurt, Germany
Professor, Biology, Goethe University Frankfurt
Director of Max Planck Institute for Brain Research
Properties of mRNAs and proteins (e.g. the transcriptomes and proteomes) distributed throughout the neuron, with a focus on how local cell biological processes, like protein synthesis, can function to allow synapses to respond rapidly and relatively specifically to bring about changes.
-
Michal Sharon
PhD, IsraelProfessor, Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
The Sharon group investigates mechanisms that control and coordinate the activity of molecular machines involved in the protein degradation pathway. Using novel native mass spectrometry approaches, in conjunction with fluorescence microscopy, biochemical and cell biology methods - generating an integrative mode of analysis combining in vitro and in vivo findings.
-
Yosef Shaul
PhD, IsraelProfessor, Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
The Shaul laboratory studies the regulation of IDP protein levels by default degradation and interaction with "nannies". They found that IDP degradation by default via the 20S proteasomes is regulated by NADH and NQO1. In addition, they revealed a new type of 26S proteasome that is ATP less but requires NADH. These findings couples IDP degradation with metabolic state of the cells.
-
David Smith
PhD, USAAssociate Professor, Department of Biochemistry, West Virginia University Health Sciences, Morgantown, WV, USA
Smith laboratory is interested in understanding how the proteasome moves and functions at a molecular level, using an energy dependent multistep process involving 1) substrate binding, 2) unfolding, 3) translocation, 4) gate-opening and 5) destruction inside of a sequestered chamber. More specifically they have a special interest in understanding how the many different regulatory “caps” that bind to the 20S proteasome catalyze aspects of this multistep process.
-
Jetze Tepe
PhD, USAAssociate Professor, Department of Chemistry, Michigan State University, East Lansing, MI, USA
Intrinsically disordered proteins (IDPs) are often referred to as “undruggable targets” and their dysregulation drives the pathogenesis of many diseases, including neurodegenerative disorders and cancer. We are exploring the proteolytic degradation of dysregulated IDPs by enhancing the proteolytic activity of the 20S proteasome using small molecules as a new therapeutic strategy to treat those disorders.
-
Eilika Weber-Ban
PhD, SwitzerlandProfessor, Department of Biology, Institute of Molecular Biology & Biophysics, ETH Zurich, Zurich, Switzerland
Research Interest
Weber-Ban laboratory investigates the structure and function of chaperone-protease complexes and associated proteins. Recently we have focused our attention on the pup-proteasome-system.
-
Jonathan Yewdell
MD, PhD, USASenior Investigator, Cellular Biology & Viral Immunology Section, National Institutes of Health, NIAID/DIR, Bethesda, MD, USA
Chief, Cell Biology Section
The Yewdell laboratory is in part interested in generation of MHC class I peptide ligands from defective ribosomal products (DRiPs) and other endogenous antigens.
Organizing committee
- Wolfgang Baumeister, Germany
- Kelvin Davies, USA
- Seth Margolis, USA
- Michal Sharon, Israel
Co- Organizer
Sponsors
82nd Katzir Conference
The Chorafas Institute for Scientific Exchange
Conference Coordinator
Inbal Azoulay
inbal.azoulay@weizmann.ac.il